Core Viewpoint - The A-share market is experiencing a slight decline, with the Shanghai Composite Index down by 0.32% and a total trading volume of 1.456 trillion yuan, indicating a cautious market sentiment [1]. Group 1: Market Performance - As of 14:05, the Shanghai Composite Index stands at 3896.93 points, reflecting a decrease of 0.32% [1]. - The total trading volume in the A-share market is reported at 1.456 trillion yuan [1]. Group 2: Moving Averages Analysis - A total of 93 A-shares have seen their 5-day moving averages cross below their 10-day moving averages, indicating potential bearish trends [1]. - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - **退市苏吴**: 5-day MA is 0.88 yuan, 10-day MA is 0.94 yuan, with a difference of -6.71% [1]. - **大有能源**: 5-day MA is 7.97 yuan, 10-day MA is 8.16 yuan, with a difference of -2.36% [1]. - **普联软件**: 5-day MA is 17.69 yuan, 10-day MA is 18.06 yuan, with a difference of -2.04% [1]. Group 3: Individual Stock Movements - **康辰药业**: Today's change is +0.52%, with a 5-day MA of 43.15 yuan and a 10-day MA of 43.81 yuan, showing a difference of -1.52% [1]. - **郑州煤电**: Today's change is -0.23%, with a 5-day MA of 4.43 yuan and a 10-day MA of 4.50 yuan, showing a difference of -1.47% [1]. - **捷荣技术**: Today's change is -5.65%, with a 5-day MA of 18.79 yuan and a 10-day MA of 18.99 yuan, showing a difference of -1.07% [1].

Core Points - The company has decided to repurchase and cancel a total of 346,000 restricted stocks due to four incentive recipients no longer qualifying for the incentive program after leaving the company [2][4][5] Group 1: Repurchase and Cancellation Details - The repurchase and cancellation of restricted stocks were approved during multiple board meetings held on April 25, June 23, and August 27, 2025 [3][4] - The repurchase involves 140,000 shares from one recipient and 206,000 shares from three other recipients [2][3] - The company has opened a dedicated securities account for the repurchase process and expects the cancellation to be completed by December 8, 2025 [5][6] Group 2: Legal and Compliance Aspects - The company has confirmed that the decision-making process and information disclosure comply with relevant laws and regulations, including the "Management Measures for Equity Incentives of Listed Companies" [7][8] - A legal opinion from Beijing Guofeng Law Firm states that the procedures followed for the repurchase and cancellation are in accordance with applicable regulations [8]

证券代码：603590 证券简称：康辰药业 公告编号：临2025-076 北京康辰药业股份有限公司关于2023年限制性股票激励计划回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 登录新浪财经APP 搜索【信披】查看更多考评等级 重要内容提示： ● 回购注销原因：根据公司《2023年限制性股票激励计划》的有关规定，鉴于4名激励对象，因离职不 再具备激励对象资格，其已获授但尚未解除限售的限制性股票由公司进行回购注销，经公司董事会、股 东大会审议同意公司回购注销4名激励对象已获授但尚未解除限售的限制性股票共计346,000股。 ● 本次注销股份的有关情况 ■ 一、本次限制性股票回购注销的决策与信息披露 北京康辰药业股份有限公司（简称"公司"）于2025年4月25日召开了第四届董事会第十六次会议和第四 届监事会第十三次会议，审议通过了《关于回购注销部分激励对象已获授但尚未解除限售的限制性股票 及调整回购价格的议案》，同意公司回购注销1名激励对象已获授但尚未解除限售的140,000股限制性股 票。 公司于2025年6月 ...

（文章来源：证券日报） 证券日报网讯 12月3日晚间，康辰药业发布公告称，鉴于4名激励对象因离职不再具备激励对象资格， 其已获授但尚未解除限售的限制性股票由公司进行回购注销，经公司董事会、股东大会审议同意公司回 购注销4名激励对象已获授但尚未解除限售的限制性股票共计346，000股。 ...

北京康辰药业股份有限公司 关于 2023 年限制性股票激励计划回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购注销原因：根据公司《2023 年限制性股票激励计划》的有关规定， 鉴于 4 名激励对象，因离职不再具备激励对象资格，其已获授但尚未解除限售的 限制性股票由公司进行回购注销，经公司董事会、股东大会审议同意公司回购注 销 4 名激励对象已获授但尚未解除限售的限制性股票共计 346,000 股。 | | | | 回购股份数量（股） | 注销股份数量（股） | 注销日期 | | | | --- | --- | --- | --- | --- | | 346,000 | 346,000 | 年 月 2025 | 12 | 日 8 | 证券代码：603590 证券简称：康辰药业 公告编号：临 2025-076 根据《上市公司股权激励管理办法》、公司《2023 年限制性股票激励计划》 的有关规定，鉴于 4 名激励对象，因离职不再具备激励对象资格，其已获授但尚 未解除限售的限制性股票共计 346, ...

北京国枫律师事务所 关于北京康辰药业股份有限公司 2023 年限制性股票激励计划 回购注销部分限制性股票实施情况的 法律意见书 国枫律证字[2023]AN138-8 号 GRANDWAY 北京国枫律师事务所 Grandway Law Offices 北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 邮编: 100005 电话（Tel） 010-88004488/66090088 传真（Fax): 010-66090016 北京国枫律师事务所 关于北京康辰药业股份有限公司 2023 年限制性股票激励计划 回购注销部分限制性股票实施情况的 法律意见书 国枫律证字[2023]AN138-8号 致:北京康辰药业股份有限公司 一、本激励计划回购注销事项履行的程序 经查验康辰药业相关董事会、监事会、股东大会的会议文件及公告,康辰药业 本次回购注销事项已履行的批准和授权及信息披露如下: 1. 2023年8月16日,公司召开 2023年第三次临时股东大会,会议审议通过了 《关于<公司 2023 年限制性股票激励计划(草案)>及其摘要的议案》《关于<公司 2023 年限制性股票激励计划实施考核管理办法>的议案》《关于 ...

Core Viewpoint - The A-share market showed a decline with the Shanghai Composite Index closing at 3878.00 points, down 0.51% and below the five-day moving average, with a total trading volume of 168.36 billion yuan [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3878.00 points, reflecting a decrease of 0.51% [1]. - The total trading volume in the A-share market reached 168.36 billion yuan [1]. Group 2: Stocks Breaking the Five-Day Moving Average - A total of 233 A-shares broke above the five-day moving average today [1]. - Notable stocks with significant deviation rates include: - Sifangda (300179) with a deviation rate of 12.01% and a daily increase of 15.37% [1]. - *ST Changyao (300391) with a deviation rate of 11.26% and a daily increase of 20.09% [1]. - Jindike (688670) with a deviation rate of 8.49% and a daily increase of 15.93% [1]. Group 3: Stocks with Smaller Deviation Rates - Stocks with smaller deviation rates that just crossed the five-day moving average include: - Jiuli Special Materials (300996) with a deviation rate of 8.38% and a daily increase of 11.38% [1]. - Zhongheng Design (603017) with a deviation rate of 8.14% and a daily increase of 9.98% [1]. - Shuangqiang Technology (001211) with a deviation rate of 7.13% and a daily increase of 9.99% [1].

Group 1 - The Shanghai Composite Index closed at 3878.89 points, below the five-day moving average, with a decline of 0.48% [1] - The total trading volume of A-shares reached 1,352.517 billion yuan [1] - A total of 193 A-shares have surpassed the five-day moving average today, with notable stocks including Sifangda, Puliansoft, and Zhongheng Design showing significant deviation rates of 12.40%, 8.97%, and 8.14% respectively [1] Group 2 - The stocks with the highest deviation rates from the five-day moving average include: - Sifangda (300179) with a price increase of 15.89% and a deviation rate of 12.40% - Puliansoft (300996) with a price increase of 12.16% and a deviation rate of 8.97% - Zhongheng Design (603017) with a price increase of 9.98% and a deviation rate of 8.14% [1] - Other notable stocks with smaller deviation rates include: - Jianmin Group, Klete, and Sanwei Equipment, which have just crossed the five-day moving average [1]

证券代码：603590 证券简称：康辰药业 公告编号：临 2025-075 北京康辰药业股份有限公司 北京康辰药业股份有限公司（以下简称"公司"）于 2025 年 10 月 15 日召开第 四届董事会第二十次会议、第四届监事会第十六次会议，审议通过了《关于以集 中竞价交易方式回购公司股份方案的议案》，同意公司使用自有资金或自筹资金以 集中竞价交易方式回购公司股份，回购股份将全部用于员工持股计划或全部用于 股权激励。回购资金总额不低于人民币 5,000 万元（含本数）且不超过人民币 10,000 万元（含本数），回购价格不超过人民币 82 元/股，回购期限为自公司董事会审议 通过回购股份方案之日起 12 个月内。具体内容详见公司于 2025 年 10 月 16 日在 指定信息披露媒体披露的《关于以集中竞价交易方式回购股份的回购报告书》。 二、回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号—回购股份》等相关法律法规规定，现将公司回购股份的进展情况公告如下： 截至 2025 年 11 月 30 日，公司已累计回购股份 397,400 股，占公司总股本的 比例为 0.2 ...

格隆汇12月1日丨康辰药业(603590.SH)公布，截至2025年11月30日，公司已累计回购股份39.74万股，占 公司总股本的比例为0.25%，购买的最高价为51.40元/股、最低价为49.69元/股，已支付的总金额为 2016.18万元。 ...